Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:vaccine
|
| gptkbp:age |
adults
children infants |
| gptkbp:alsoKnownAs |
gptkb:PCV13
gptkb:Pneumococcal_13-valent_Conjugate_Vaccine |
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 2010 |
| gptkbp:ATCCode |
gptkb:J07AL02
|
| gptkbp:broadcastOn |
multiple doses
|
| gptkbp:contains |
gptkb:CRM197_protein
polysaccharide antigens |
| gptkbp:contraindication |
severe allergic reaction to any component
|
| gptkbp:countryOfOperation |
gptkb:Australia
gptkb:Canada gptkb:European_Union gptkb:United_States |
| gptkbp:indication |
prevention of pneumococcal disease
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:numberOfSerotypes |
13
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:protectedBy |
gptkb:Streptococcus_pneumoniae
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
fatigue injection site pain irritability |
| gptkbp:storage |
2-8°C
|
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:Wyeth
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Prevnar 13
|